Home » Topics » Regulatory » Patents

Patents
RSS

Principia Biopharma presents FGFR inhibitors

Aug. 27, 2015

Incyte divulges KDM1A inhibitors

Aug. 27, 2015

RespiVert and Topivert Pharma patent anti-inflammatory kinase inhibitors

Aug. 27, 2015

Bayer Schering Pharma discloses BRD4 inhibitors

Aug. 27, 2015

Oncothyreon patents Chk1 inhibitors

Aug. 26, 2015

Vitae Pharmaceuticals discloses ROR-gamma inhibitors

Aug. 26, 2015

MedoLution introduces T790M EGFR kinase inhibitors

Aug. 26, 2015

Axxam divulges P2X7 antagonists

Aug. 26, 2015

Taiho patents JAK3 inhibitors

Aug. 26, 2015

Lundbeck discloses PDE1 inhibitors

Aug. 26, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...